1) bromodeoxyuridine
['brəuməudi,ɔksi'juəridi:n]
5-溴脱氧尿苷
2) 5-bromodeoxyuridine
5-溴脱氧尿核苷
1.
In this study, we employed LiCl-pilocarpine-induced temporal lobe epilepsy rat model, used 5-bromodeoxyuridine (BrdU) to label newborn cells, and sought to examine the effects of lamotrigine on the neurogenesis in the SGZ after seizures induced by lithium-pilocarpine.
为此,本课题采用锂-匹罗卡品诱发大鼠颞叶癫癎模型,利用5-溴脱氧尿核苷(BrdU)标记分裂细胞,通过免疫组织化学方法观察LTG对成年癫癎大鼠海马神经前体细胞增殖、存活、分化以及迁移的影响,以期为临床应用LTG提供更多的实验依据。
3) BrdU
5-溴脱氧尿嘧啶核苷
1.
Technical explore on mesenchymal stem cells in bone marrow using BrdU labelling;
5-溴脱氧尿嘧啶核苷标记骨髓间充质干细胞的技术探讨
2.
Objective To study the feasibility of labeling adipose-derived adult stem cells with BrdU.
目的探讨5-溴脱氧尿嘧啶核苷(BrdU)标记脂肪成体干细胞(adipose-derived adult stem cells,ADASCs)的可行性。
3.
AIM: To study the differentiation characteristics and the optimal dosage and timing for bromodeoxyuridine (Brdu) labeling of rat bone marrow-derived mesenchymal stem cells (MSCs) in vitro.
目的:探讨骨髓间充质干细胞(MSCs)在体外的诱导分化及5-溴脱氧尿嘧啶核苷(Brdu)标记MSCs的可行性。
4) bromodeoxyuridine
['brəuməudi,ɔksi'juəridi:n]
5-溴脱氧尿嘧啶核苷
1.
To explore the best time and best dose for labeling the MSCs with bromodeoxyuridine(BrdU)in vitro,so as to attain the best tracing guide line of applying MSCs to future research.
目的 建立成人骨髓间充质干细胞(MSCs)体外分离培养和鉴定的方法,探讨连续培养的骨髓间充质干细胞应用5-溴脱氧尿嘧啶核苷(BrdU)标记的稳定性、最佳时间和剂量,争取确定应用骨髓间充质干细胞进行研究最好的示踪指标。
5) BrdU incorporation assays
5-溴脱氧尿苷掺入法
6) 5-bromo-2-BrdU
5-溴-2-脱氧尿核苷
补充资料：2'-溴-2'-脱氧-3', 5'-双乙酰基-5'-甲基尿苷
分子式：C14H17BrN2O7
分子量：405.00
CAS号：暂无
性质：该品为类白或微黄结晶粉末。
制备方法：暂无
用途：暂无
分子量：405.00
CAS号：暂无
性质：该品为类白或微黄结晶粉末。
制备方法：暂无
用途：暂无
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条